Enzymolysis-based RNA pull-down identifies YTHDC2 as an inhibitor of antiviral innate response
- PMID: 37776518
- DOI: 10.1016/j.celrep.2023.113192
Enzymolysis-based RNA pull-down identifies YTHDC2 as an inhibitor of antiviral innate response
Abstract
The innate immune response must be terminated in a timely manner at the late stage of infection to prevent unwanted inflammation. The role of m6A-modified RNAs and their binding partners in this process is not well known. Here, we develop an enzymolysis-based RNA pull-down (eRP) method that utilizes the immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) to fish out m6A-modified RNA-associated proteins. We apply eRP to capture the methylated single-stranded RNA (ssRNA) probe-associated proteins and identify YT521-B homology domain-containing 2 (YTHDC2) as the m6A-modified interferon β (IFN-β) mRNA-binding protein. YTHDC2, induced in macrophages at the late stage of virus infection, recruits IFN-stimulated exonuclease ISG20 (IFN-stimulated exonuclease gene 20) to degrade IFN-β mRNA, consequently inhibiting antiviral innate immune response. In vitro and in vivo deficiency of YTHDC2 increases IFN-β production at the late stage of viral infection. Our findings establish an eRP method to effectively identify RNA-protein interactions and add mechanistic insight to the termination of innate response for maintaining homeostasis.
Keywords: CP: Immunology; RNA pull-down; RNA-binding proteins; YTHDC2; immunoglobulin G-degrading enzyme; innate immunity; mRNA degradation.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
The Interferon-Induced Exonuclease ISG20 Exerts Antiviral Activity through Upregulation of Type I Interferon Response Proteins.mSphere. 2018 Sep 19;3(5):e00209-18. doi: 10.1128/mSphere.00209-18. mSphere. 2018. PMID: 30232164 Free PMC article.
-
Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.PLoS Pathog. 2020 Feb 14;16(2):e1008338. doi: 10.1371/journal.ppat.1008338. eCollection 2020 Feb. PLoS Pathog. 2020. PMID: 32059034 Free PMC article.
-
Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.Oncotarget. 2016 Oct 18;7(42):68179-68193. doi: 10.18632/oncotarget.11907. Oncotarget. 2016. PMID: 27626689 Free PMC article.
-
Modifying the antiviral innate immune response by selective writing, erasing, and reading of m6A on viral and cellular RNA.Cell Chem Biol. 2024 Jan 18;31(1):100-109. doi: 10.1016/j.chembiol.2023.12.004. Epub 2024 Jan 3. Cell Chem Biol. 2024. PMID: 38176419 Review.
-
RNA regulatory mechanisms that control antiviral innate immunity.Immunol Rev. 2021 Nov;304(1):77-96. doi: 10.1111/imr.13019. Epub 2021 Aug 17. Immunol Rev. 2021. PMID: 34405416 Free PMC article. Review.
Cited by
-
The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases.J Transl Med. 2024 May 24;22(1):490. doi: 10.1186/s12967-024-05293-6. J Transl Med. 2024. PMID: 38790013 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous